Inglat-O-Ball
510(k) K904774
Active
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK904774 | Date7 Dec 1990 | StatusActive |
Recalls
-
- Ongoing Z-1631-2022
Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
-
- Terminated Z-1152-2021
The affected Milex Gellhorn pessaries were incorrectly manufactured with a long stem (2.170 ), instead of a short stem (1.670 or 1.960 nominal height) as required. The length discrepancy does not meet the released print dimensions.
-
- Terminated Z-2054-2017
The current secondary packaging, a box, incorrectly states that the product is latex free. The product is made with 100% latex. The label on the package that contains the product and the Instructions for Use (IFU) correctly states that the pessary is manufactured from latex rubber.
-
- Terminated Z-0253-2016
The products have been identified to have incorrect size prints on the MILEX PESSARY KIT packaging. While the Pessary pouch is marked with correct size, an incorrect label on the packaging does not meet the required release specification.
-
- Terminated Z-0208-2015
- Terminated Z-0207-2015
Incorrect expiration date printed on the MILEX PESSARY KIT packaging
-
- Terminated Z-1011-2013
- Terminated Z-1004-2013
- Terminated Z-1007-2013
- Terminated Z-1009-2013
- Terminated Z-1005-2013
- Terminated Z-1010-2013
- Terminated Z-1006-2013
- Terminated Z-1012-2013
- Terminated Z-1008-2013
Pessary mislabeled outer package may not reflect the size of the product contained in the package
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HHW
- Device Class
- Class II
- Regulation
- 21 CFR Part 884.3575
- Advisory Committee
- Obstetrics/Gynecology
- FDA Decision
- SESE Substantially Equivalent